IndraLab

Statements


USP8 inhibits ERBB2. 3 / 3
| 3

reach
"The USP8 inhibited HER-2 positive GC cell proliferation and migration in vivo and in vitro and probably served as a novel potential therapeutic biomarker for HER-2 positive GC."

reach
"USP8 inhibited the migration and proliferation of HER-2 positive gastric cancer cells through the PI3K/AKT signaling pathway [31]."

reach
"USP8 Inhibitor Suppresses HER-2 Positive Gastric Cancer Cell Proliferation and Metastasis via the PI3K and AKT Signaling Pathway."